Lv5
1025 积分 2021-08-08 加入
Response to PCSK9 Inhibition Based on LDL Receptor Function in Familial Hypercholesterolemia
7小时前
求助中
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
15小时前
待确认
Safety and Efficacy of Oral PCSK9 Inhibitors in Hypercholesterolemia: A Systematic Review and Network Meta-Analysis
16小时前
待确认
Phase 3 study results for oral PCSK9 inhibition with enlicitide
16小时前
待确认
Comparative efficacy and safety of novel Lp(a)-lowering therapies for ASCVD prevention: A network meta-analysis
16小时前
待确认
Efficacy and Safety of Apolipoprotein C‐ III Inhibitors in Hypertriglyceridemia: A Network Meta‐Analysis of Randomised Controlled Trials
16小时前
待确认
Apolipoprotein C-III inhibitors for the treatment of hypertriglyceridemia: a meta-analysis of randomized controlled trials
16小时前
待确认
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
1天前
待确认
PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta-analysis of Randomized Clinical Trials
1天前
待确认
Inhibitors of apolipoprotein C3, triglyceride levels, and risk of pancreatitis: a systematic review and meta-analysis
2天前
已完结
皖公网安备34019202002308
